<p class="MsoNormal"><span style="line-height:115%"><span style="color:#000000"><span style="background-color:#ffffff">Drugs Controller General of India (DCGI) may permit the</span></span></span> <span style="line-height:115%"><span style="color:#000000"><span style="background-color:#ffffff">pharmaceutical company, Dr. Reddy’s Laboratories, to resume its Phase II and Phase III human clinical trials of the Russian vaccine Sputnik V in India, said ITP. </span></span></span></p>
